Oncodesign Services

About Oncodesign Services

Oncodesign Services is a contract research organization (CRO) that specializes in drug discovery and precision medicine. The company focuses on developing innovative therapies for cancers and other serious diseases with high medical needs. Oncodesign Services operates in the pharmaceutical and biotechnology markets, providing a range of services including medicinal chemistry, in vitro biology, DMPK (drug metabolism and pharmacokinetics), bioanalysis, formulation, immunogenicity, biomarkers, pharmaco-imaging, bioconjugation, and radiochemistry. The company also offers in vivo pharmacology services with a focus on oncology, immuno-oncology, molecular radiotherapy, and various tumor models including orthotopic, metastatic, and humanized models. Oncodesign Services serves pharmaceutical companies, biotech firms, and academic institutions, helping them advance their drug discovery projects from early-stage research to preclinical development. The business model is service-based, generating revenue through contract research agreements and collaborative partnerships. With over 230 employees, the company leverages its expertise and technological innovation to contribute to the discovery of effective treatments for diseases with unmet medical needs.